# R1 Clinical-Safety Review — subependymal_giant_cell_astrocytoma

APPROVE

## Verdict
APPROVE. Clinically safe, grounded in DeVita/NCCN standard of care, dose-free, and appropriately scoped as decision-support. No adversarial .verdict.md present, so no unresolved-flag block applies.

## 1. Safety
No unsafe, misleading, or harmful-if-followed statements. Every therapeutic claim is hedged ("often curative", "therapeutic option", "reserved for lesions that progress"). Hydrocephalus/raised-ICP is correctly flagged as the driver of urgency with an explicit urgent-neurosurgery escalation trigger (worsening headache, vomiting, papilloedema, declining consciousness, focal deficit, marked seizure-pattern change). No absolute directive that oversteps decision-support.

## 2. Grounding
DeVita-attributed claims are accurate: SEGA grouped within the astroglial-variant grade I low-grade glioma cluster (with pilocytic astrocytoma, ganglioglioma, PXA); surgery alone often curative for that group; everolimus FDA-approved for SEGA with mTORC1-inhibition mechanism tied to TSC1/TSC2 (hamartin/tuberin) loss. These match real standard of care (everolimus SEGA approval, EXIST-1 basis). Non-DeVita-specific claims (CSF diversion via VP shunt/ETV, serial MRI surveillance, TSC multidisciplinary/genetic-counselling referral, watch-and-wait for stable subependymal nodules) are each explicitly relabelled "general oncology standard, not from DeVita's section on this disease." No regimen fabricated or outdated. No claim mis-attributed to DeVita.

## 3. Dose-free
Confirmed. Grep for numeric doses/mg/m2/AUC/schedules returned no matches. "Grade I" is a WHO grade, not a dose.

## 4. Scope
Appropriately hedged throughout; frames choices by clinical scenario, defers to neurosurgery/neuro-oncology, and states an explicit "Deliberate omission" of radiotherapy/cytotoxic chemo/line-of-therapy sequencing rather than inventing one. Decision-support tone, not directive.

## 5. Adversarial flags
No .verdict.md at the sidecar path — block-on-unresolved-flag rule does not trigger.

## Notes (advisory, non-blocking)
- The inline attribution parentheticals are verbose but are a grounding feature, not a defect — they correctly separate DeVita-specific from general-standard claims. If the KB render pipeline strips or displays raw text, consider condensing at render time only; content is sound as-is.

goldens changed: no (intended: n/a — reference narrative, no engine/rule/golden touched)
